JP2012505227A5 - - Google Patents

Download PDF

Info

Publication number
JP2012505227A5
JP2012505227A5 JP2011531146A JP2011531146A JP2012505227A5 JP 2012505227 A5 JP2012505227 A5 JP 2012505227A5 JP 2011531146 A JP2011531146 A JP 2011531146A JP 2011531146 A JP2011531146 A JP 2011531146A JP 2012505227 A5 JP2012505227 A5 JP 2012505227A5
Authority
JP
Japan
Prior art keywords
antibody
agent
antagonist
osteoporosis
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011531146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012505227A (ja
JP5860699B2 (ja
Filing date
Publication date
Priority claimed from US12/246,715 external-priority patent/US7837994B2/en
Application filed filed Critical
Priority claimed from PCT/US2009/059865 external-priority patent/WO2010042634A1/en
Publication of JP2012505227A publication Critical patent/JP2012505227A/ja
Publication of JP2012505227A5 publication Critical patent/JP2012505227A5/ja
Application granted granted Critical
Publication of JP5860699B2 publication Critical patent/JP5860699B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011531146A 2008-10-07 2009-10-07 骨粗鬆症の治療のためのｉｌ−２０アンタゴニストの使用 Expired - Fee Related JP5860699B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/246,715 US7837994B2 (en) 2008-10-07 2008-10-07 Use of anti-IL-20 antibody for treating osteoporosis
US12/246,715 2008-10-07
US23866109P 2009-08-31 2009-08-31
US61/238,661 2009-08-31
PCT/US2009/059865 WO2010042634A1 (en) 2008-10-07 2009-10-07 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015214727A Division JP2016041730A (ja) 2008-10-07 2015-10-30 リウマチ性関節炎の治療のためのｉｌ−２０アンタゴニストの使用

Publications (3)

Publication Number Publication Date
JP2012505227A JP2012505227A (ja) 2012-03-01
JP2012505227A5 true JP2012505227A5 (https=) 2012-11-22
JP5860699B2 JP5860699B2 (ja) 2016-02-16

Family

ID=42100943

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011531146A Expired - Fee Related JP5860699B2 (ja) 2008-10-07 2009-10-07 骨粗鬆症の治療のためのｉｌ−２０アンタゴニストの使用
JP2015214727A Pending JP2016041730A (ja) 2008-10-07 2015-10-30 リウマチ性関節炎の治療のためのｉｌ−２０アンタゴニストの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015214727A Pending JP2016041730A (ja) 2008-10-07 2015-10-30 リウマチ性関節炎の治療のためのｉｌ−２０アンタゴニストの使用

Country Status (7)

Country Link
EP (1) EP2340039B1 (https=)
JP (2) JP5860699B2 (https=)
KR (1) KR101691534B1 (https=)
CN (1) CN102281898B (https=)
CA (1) CA2739794A1 (https=)
DK (1) DK2340039T3 (https=)
WO (1) WO2010042634A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103052403B (zh) 2010-04-16 2014-10-22 成功大学 通过阻断il-20受体活性治疗与il-20受体介导的信号通路相关的病症
WO2014006230A1 (en) 2012-07-06 2014-01-09 Novo Nordisk A/S Il-20 epitopes and il-20 ligands
CA2878825A1 (en) * 2012-07-10 2014-01-16 The Uab Research Foundation Compositions and methods for modulation of il-20 family cytokine activity
US8603470B1 (en) * 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US9376490B2 (en) * 2014-04-01 2016-06-28 National Cheng Kung University Treatment of inflammatory pain using IL-20 antagonists
CN107249630A (zh) * 2014-11-24 2017-10-13 国家健康与医学研究院 通过il‑20r的拮抗作用治疗慢性阻塞性肺疾病的急性加重
US9982043B2 (en) 2016-06-03 2018-05-29 National Cheng Kung University Use of IL-20 antagonists for treating pancreatic cancer
KR101796025B1 (ko) 2017-04-25 2017-11-10 가톨릭대학교 산학협력단 사포그릴레이트, 프라바스타틴 및 tnf-억제제를 유효성분으로 포함하는 죽상동맥경화증 예방 또는 치료용 약학조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX336813B (es) * 1996-02-09 2016-02-02 Abbvie Biotechnology Ltd Anticuerpos humanos que ligan el tnfa humano.
US6649779B2 (en) * 1997-05-02 2003-11-18 Wyeth Estrenes
IL136076A0 (en) * 1997-11-26 2001-05-20 Zymogenetics Inc Mammalian cytokin-like polypeptide -10
US20030148955A1 (en) * 1999-04-19 2003-08-07 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
EP1244708B8 (en) * 1999-12-23 2007-03-07 ZymoGenetics, Inc. Method for treating inflammation
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
AU783473B2 (en) * 1999-12-23 2005-10-27 Zymogenetics Inc. Soluble interleukin-20 receptor
US20050143333A1 (en) * 2001-05-18 2005-06-30 Sirna Therapeutics, Inc. RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
EP1429779A2 (en) * 2001-09-21 2004-06-23 Merck & Co., Inc. Androstanes as androgen receptor modulators
US20040235728A1 (en) * 2001-11-08 2004-11-25 Stoch Selwyn Aubrey Compositions and methods for treating osteoporosis
US7435800B2 (en) * 2003-05-23 2008-10-14 Chi-Mei Medical Center Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation
WO2005052001A2 (en) * 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
KR101351165B1 (ko) * 2006-03-30 2014-01-14 도레이 카부시키가이샤 수지상 폴리에스테르, 그의 제조 방법 및 열가소성 수지 조성물
JP5330829B2 (ja) * 2006-08-04 2013-10-30 憲弘 西本 関節リウマチ患者の治療予後予測方法

Similar Documents

Publication Publication Date Title
JP2012505227A5 (https=)
US8426562B2 (en) Methods and compositions for modulating tumor cell activity
JP2018506961A5 (https=)
JP2017149720A5 (https=)
JP2009529920A5 (https=)
US20220041721A1 (en) Cd3 antigen binding fragment and application thereof
JP2020504076A5 (https=)
JP2017535257A5 (https=)
JP2018519364A5 (https=)
RU2018108048A (ru) Новые анти-pd-1 антитела
JP2012012402A5 (https=)
JP2012525854A5 (https=)
US20240117035A1 (en) Cldn18.2/cd3 bispecific antibodies for the therapy of cldn18.2-expressing solid tumors
JP2022514179A5 (https=)
JP2025500971A5 (https=)
JP2013519367A5 (https=)
JP2007510664A5 (https=)
JP2019512523A5 (https=)
JP2023549537A5 (https=)
JP2007526908A5 (https=)
JP2021520201A5 (https=)
JP2022512905A5 (https=)
TW202300527A (zh) 使用ｇｒｅｍ１拮抗劑治療疾病的方法
WO2019172165A1 (ja) 異所性骨化の治療又は予防のための医薬組成物
CN120712286A (zh) 抗体、抗原结合片段和使用方法